Compile Data Set for Download or QSAR
Report error Found 67 Enz. Inhib. hit(s) with Target = 'Bcl-2-like protein 1/Bcl2-associated agonist of cell death [103-127,M117N]'
LigandPNGBDBM562384(US11401278, Example 55 | (+)-4-chloro-14-cycloprop...)
Affinity DataIC50: 1.30E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562387(US11401278, Example 58 | (+)-4-chloro-3,14-diethyl...)
Affinity DataIC50: 1.40E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562339(US11401278, Example 12 | (−)-2,3,14-Trimethy...)
Affinity DataIC50: 1.50E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562385(US11401278, Example 56 | (rac)-4-chloro-3,14-dieth...)
Affinity DataIC50: 1.60E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562379(US11401278, Example 50 | (rac)-4-chloro-7-{3-[(6-f...)
Affinity DataIC50: 1.60E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562383(US11401278, Example 54 | (+)-4-chloro-14-cycloprop...)
Affinity DataIC50: 1.60E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562382(US11401278, Example 53 | (rac)-4-chloro-14-cyclopr...)
Affinity DataIC50: 1.60E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562388(US11401278, Example 59 | (rac)-4-chloro-3-ethyl-7-...)
Affinity DataIC50: 1.60E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562331(US11401278, Example 4 | US11401278, Example 5 | (r...)
Affinity DataIC50: 1.80E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562371(US11401278, Example 44 | US11401278, Example 46 | ...)
Affinity DataIC50: 1.80E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562391(US11401278, Example 62 | (+)-4-chloro-3-ethyl-7-{3...)
Affinity DataIC50: 1.80E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562369(US11401278, Example 42 | (−)-4-chloro-14-cyc...)
Affinity DataIC50: 1.80E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562364(US11401278, Example 37 | (−)-4-chloro-3-ethy...)
Affinity DataIC50: 1.80E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562367(US11401278, Example 40 | (rac)-4-chloro-14-cyclopr...)
Affinity DataIC50: 1.90E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562392(US11401278, Example 63 | (+)-4-chloro-3-ethyl-7-{3...)
Affinity DataIC50: 1.90E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562368(US11401278, Example 41 | (rac)-4-chloro-14-cyclopr...)
Affinity DataIC50: 1.90E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562350(US11401278, Example 23 | (rac)-13-Chloro-12-ethyl-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562377(US11401278, Example 48 | US11401278, Example 65 | ...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562351(US11401278, Example 24 | (rac)-13-Chloro-12-ethyl-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562397(US11401278, Example 68 | (rac)-4-chloro-3-ethyl-7-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562353(US11401278, Example 26 | (rac)-13-Fluoro-8,11,12-t...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562352(US11401278, Example 25 | (rac)-13-Fluoro-1-(3-((6-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562354(US11401278, Example 27 | (rac)-1-(3-((2,3-Dihydro-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562390(US11401278, Example 61 | (+)-4-chloro-3-ethyl-7-{3...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562345(US11401278, Example 18 | 12-Ethyl-8,9,11-trimethyl...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562344(US11401278, Example 17 | (rac)-12-Ethyl-11-methyl-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562346(US11401278, Example 19 | (rac)-13-Chloro-12-ethyl-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562393(US11401278, Example 64 | (+)-4-chloro-3-ethyl-7-{3...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562347(US11401278, Example 20 | (rac)-13-Chloro-12-ethyl-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562377(US11401278, Example 48 | US11401278, Example 65 | ...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562349(US11401278, Example 22 | (rac)-13-Chloro-1-(3-(4-c...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562348(US11401278, Example 21 | (rac)-13-Chloro-1-(3-((2,...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562361(US11401278, Example 34 | (rac)-12-Ethyl-13-fluoro-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562360(US11401278, Example 33 | (rac)-1-(3-(4-Chloro-3,5-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562362(US11401278, Example 35 | (rac)-12-Ethyl-13-fluoro-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562363(US11401278, Example 36 | (+)-4-chloro-3-ethyl-7-{3...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562365(US11401278, Example 38 | (−)-4-fluoro-7-{3-[...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562406(US11401278, Example 77 | (rac)-13-chloro-12-ethyl-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562355(US11401278, Example 28 | (rac)-1-(3-(4-Chloro-3,5-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562357(US11401278, Example 30 | (rac)-13-Fluoro-1-(34(4-f...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562356(US11401278, Example 29 | (rac)-13-Fluoro-8,11,12-t...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562358(US11401278, Example 31 | (rac)-12-Ethyl-13-fluoro-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562359(US11401278, Example 32 | (rac)-1-(3-((2,3-Dihydro-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562256(US11401278, Example 1 | US11401278, Example 2 | US...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562371(US11401278, Example 44 | US11401278, Example 46 | ...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562371(US11401278, Example 44 | US11401278, Example 46 | ...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562256(US11401278, Example 1 | US11401278, Example 2 | US...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562374(US11401278, Example 47 | (rac)-15-chloro-1-(3-((6-...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562331(US11401278, Example 4 | US11401278, Example 5 | (r...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

LigandPNGBDBM562256(US11401278, Example 1 | US11401278, Example 2 | US...)
Affinity DataIC50: 2.00E+4nMAssay Description:BCL-XL/Bad BH3 Peptide (BCL-XL Assay): The assay was initiated by addition of 2 μl of a 2.5-fold concentrated His-BCL-XL solution (usually for a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2022
Entry Details
US Patent

Displayed 1 to 50 (of 67 total ) | Next | Last >>
Jump to: